Suppressor of cytokine signalling (SOCS) proteins as guardians of inflammatory responses critical for regulating insulin sensitivity

Biochemical Journal

Volumn 461, Issue 2, 2014, Pages 177-188

  Galic, Sandra ^a   Sachithanandan, Nirupa ^a   Kay, Thomas W ^a   Steinberg, Gregory R ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Immunometabolism; Insulin sensitivity; Macrophage, metabolic disease; Overnutrition; T cell

Indexed keywords

INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; SUPPRESSOR OF CYTOKINE SIGNALING 4; SUPPRESSOR OF CYTOKINE SIGNALING 5; SUPPRESSOR OF CYTOKINE SIGNALING 6; SUPPRESSOR OF CYTOKINE SIGNALING 7; UNCLASSIFIED DRUG;

GLUCOSE HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER; MACROPHAGE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SKELETAL MUSCLE; T LYMPHOCYTE; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ANIMALS; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIVER; MACROPHAGES; MICE; MUSCLE, SKELETAL; OBESITY; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; T-LYMPHOCYTES;

EID: 84903291617     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20140143     Document Type: Review

References (145)

1. Pischon, T., Boeing, H., Hoffmann, K., Bergmann, M., Schulze, M. B., Overvad, K. Y., van der Schouw, T. E., Spencer, K. G., Moons, A., Tjonneland, J. et al. (2008) General and abdominal adiposity and risk of death in Europe. N. Engl. J. Med. 359, 2105-2120 CrossRef PubMed
2. Zimmet, P., Alberti, K. G. and Shaw, J. (2001) Global and societal implications of the diabetes epidemic. Nature 414, 782-787 CrossRef PubMed (Pubitemid 34000780)
3. Galic, S., Oakhill, J. S. and Steinberg, G. R. (2010) Adipose tissue as an endocrine organ. Mol. Cell. Endocrinol. 316, 129-139 CrossRef PubMed
4. Hotamisligil, G. S. (2006) Inflammation and metabolic disorders. Nature 444, 860-867 CrossRef PubMed
5. Olefsky, J. M. and Glass, C. K. (2010) Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72, 219-246 CrossRef PubMed
6. Steinberg, G. R. (2007) Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance. Cell Cycle 6, 888-894 CrossRef PubMed
7. Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., Miyazaki, T. et al. (1997) A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387, 921-924 CrossRef PubMed (Pubitemid 27289595)
8. Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K. et al. (1997) Structure and function of a new STAT-induced STAT inhibitor. Nature 387, 924-929 CrossRef PubMed (Pubitemid 27289596)
9. Starr, R. and Hilton, D. J. (1998) SOCS: suppressors of cytokine signalling. Int. J. Biochem. Cell Biol. 30, 1081-1085 CrossRef PubMed (Pubitemid 28484830)
10. Hilton, D. J., Richardson, R. T., Alexander, W. S., Viney, E. M., Willson, T. A., Sprigg, N. S., Starr, R., Nicholson, S. E., Metcalf, D. and Nicola, A. (1998) Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. U.S.A. 95, 114-119 CrossRef PubMed (Pubitemid 28103916)
11. Yoshimura, A., Ohkubo, T., Kiguchi, T., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., Hara, T. and Miyajima, A. (1995) A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 14, 2816-26 PubMed
12. Kamura, T., Burian, D., Yan, Q., Schmidt, S. L., Lane, W. S., Querido, E., Branton, P. E., Shilatifard, A., Conaway, R. C. and Conaway, J. W. (2001) Muf1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase. J. Biol. Chem. 276, 29748-29753 CrossRef PubMed
13. Kamura, T., Sato, S., Haque, D., Liu, L., Kaelin, Jr, W. G., Conaway, R. C. and Conaway, J. W. (1998) The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 12, 3872-3881 CrossRef PubMed (Pubitemid 29024849)
14. Yasukawa, H., Misawa, H., Sakamoto, H., Masuhara, M., Sasaki, A., Wakioka, T., Ohtsuka, S., Imaizumi, T., Matsuda, T., Ihle, J. N. and Yoshimura, A. (1999) The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18, 1309-1320 CrossRef PubMed (Pubitemid 29110315)
15. Hwang, M. N., Min, C. H., Kim, H. S., Lee, H., Yoon, K. A., Park, S. Y., Lee, E. S. and Yoon, S. (2007) The nuclear localization of SOCS6 requires the N-terminal region and negatively regulates Stat3 protein levels. Biochem. Biophys. Res. Commun. 360, 333-338 CrossRef PubMed (Pubitemid 47044839)
16. Martens, N., Wery, M., Wang, P., Braet, F., Gertler, A., Hooghe, R., Vandenhaute, J. and Hooghe-Peters, E. L. (2004) The suppressor of cytokine signaling (SOCS)-7 interacts with the actin cytoskeleton through vinexin. Exp. Cell Res. 298, 239-248 CrossRef PubMed (Pubitemid 38887323)
17. Feng, Z. P., Chandrashekaran, I. R., Low, A., Speed, T. P., Nicholson, S. E. and Norton, R. S. (2012) The N-terminal domains of SOCS proteins: a conserved region in the disordered N-termini of SOCS4 and 5. Proteins 80, 946-957 CrossRef PubMed
18. Auernhammer, C. J., Bousquet, C. and Melmed, S. (1999) Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc. Natl. Acad. Sci. U.S A. 96, 6964-6969 CrossRef PubMed (Pubitemid 29274993)
19. Matsumoto, A., Masuhara, M., Mitsui, K., Yokouchi, M., Ohtsubo, M., Misawa, H., Miyajima, A. and Yoshimura, A. (1997) CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 89, 3148-3154 PubMed
20. Mui, A. L., Wakao, H., Kinoshita, T., Kitamura, T. and Miyajima, A. (1996) Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J. 15, 2425-2433 PubMed (Pubitemid 26151182)
21. Saito, H., Morita, Y., Fujimoto, M., Narazaki, M., Naka, T. and Kishimoto, T. (2000) IFN regulatory factor-1-mediated transcriptional activation of mouse STAT-induced STAT inhibitor-1 gene promoter by IFN-γ. J. Immunol. 164, 5833-5843 CrossRef PubMed (Pubitemid 30389827)
22. Chen, X. P., Losman, J. A., Cowan, S., Donahue, E., Fay, S., Vuong, B. Q., Nawijn, M. C., Capece, D., Cohan, V. L. and Rothman, P. (2002) Pim serine/threonine kinases regulate the stability of Socs-1 protein. Proc. Natl. Acad. Sci. U.S.A. 99, 2175-2180 CrossRef PubMed (Pubitemid 34169034)
23. Li, L., Gronning, L. M., Anderson, P. O., Li, S., Edvardsen, K., Johnston, J., Kioussis, D., Shepherd, P. R. and Wang, P. (2004) Insulin induces SOCS-6 expression and its binding to the p85 monomer of phosphoinositide 3-kinase, resulting in improvement in glucose metabolism. J. Biol. Chem. 279, 34107-34114 CrossRef PubMed (Pubitemid 39318032)
24. Piessevaux, J., Lavens, D., Montoye, T., Wauman, J., Catteeuw, D., Vandekerckhove, J., Belsham, D., Peelman, F. and Tavernier, J. (2006) Functional cross-modulation between SOCS proteins can stimulate cytokine signaling. J. Biol. Chem. 281, 32953-32966 CrossRef PubMed (Pubitemid 46036680)
25. Tannahill, G. M., Elliott, J., Barry, A. C., Hibbert, L., Cacalano, N. A. and Johnston, J. A. (2005) SOCS2 can enhance interleukin-2 (IL-2) and IL-3 signaling by accelerating SOCS3 degradation. Mol. Cell. Biol. 25, 9115-9126 CrossRef PubMed (Pubitemid 41429099)
26. Magrangeas, F., Apiou, F., Denis, S., Weidle, U., Jacques, Y. and Minvielle, S. (2000) Cloning and expression of CIS6, chromosome assignment to 3p22 and 2p21 by in situ hybridization. Cytogenet. Cell. Genet. 88, 78-81 CrossRef PubMed (Pubitemid 30175601)
27. Starr, R., Willson, T. A., Viney, E. M., Murray, L. J., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A. and Hilton, D. J. (1997) A family of cytokine-inducible inhibitors of signalling. Nature 387, 917-921 CrossRef PubMed (Pubitemid 27289594)
28. Metcalf, D., Greenhalgh, C. J., Viney, E., Willson, T. A., Starr, R., Nicola, N. A., Hilton, D. J. and Alexander, W. S. (2000) Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405, 1069-1073 CrossRef PubMed (Pubitemid 30447793)
29. Banks, A. S., Li, J., McKeag, L., Hribal, M. L., Kashiwada, M., Accili, D. and Rothman, P. B. (2005) Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans. J. Clin. Invest. 115, 2462-2471 CrossRef PubMed (Pubitemid 41266208)
30. Ueki, K., Kondo, T. and Kahn, C. R. (2004) Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol. Cell. Biol. 24, 5434-5446 CrossRef PubMed (Pubitemid 38738176)
31. Ueki, K., Kondo, T., Tseng, Y. H. and Kahn, C. R. (2004) Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc. Natl. Acad. Sci. U.S.A. 101, 10422-10427 CrossRef PubMed (Pubitemid 38924941)
32. Emanuelli, B., Peraldi, P., Filloux, C., Chavey, C., Freidinger, K., Hilton, D. J., Hotamisligil, G. S. and Van Obberghen, E. (2001) SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-α in the adipose tissue of obese mice. J. Biol. Chem. 276, 47944-47949 CrossRef PubMed
33. Shi, H., Tzameli, I., Bjorbaek, C. and Flier, J. S. (2004) Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling. J. Biol. Chem. 279, 34733-34740 CrossRef PubMed (Pubitemid 39318104)
34. Uysal, K. T., Wiesbrock, S. M., Marino, M. W. and Hotamisligil, G. S. (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389, 610-614 CrossRef PubMed (Pubitemid 27446179)
35. Wang, Q., Miyakawa, Y., Fox, N. and Kaushansky, K. (2000) Interferon-α directly represses megakaryopoiesis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1. Blood 96, 2093-2099 PubMed
36. Steinberg, G. R., Smith, A. C., Van Denderen, B. J., Chen, Z., Murthy, S., Campbell, D. J., Heigenhauser, G. J., Dyck, D. J. and Kemp, B. E. (2004) AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females. J. Clin. Endocrinol. Metab. 89, 4575-4580 CrossRef PubMed (Pubitemid 39244472)
37. Steinberg, G. R., Smith, A. C., Wormald, S., Malenfant, P., Collier, C. and Dyck, D. J. (2004) Endurance training partially reverses dietary-induced leptin resistance in rodent skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 286, E57-E63 CrossRef PubMed (Pubitemid 38036610)
38. Watt, M. J., Dzamko, N., Thomas, W. G., Rose-John, S., Ernst, M., Carling, D., Kemp, B. E., Febbraio, M. A. and Steinberg, G. R. (2006) CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. Nat. Med. 12, 541-548 CrossRef PubMed
39. Wang, J., Obici, S., Morgan, K., Barzilai, N., Feng, Z. and Rossetti, L. (2001) Overfeeding rapidly induces leptin and insulin resistance. Diabetes 50, 2786-2791 CrossRef PubMed (Pubitemid 33733130)
40. Zhang, X., Zhang, G., Zhang, H., Karin, M., Bai, H. and Cai, D. (2008) Hypothalamic IKKβ/NF-κB and ER stress link overnutrition to energy imbalance and obesity. Cell 135, 61-73 CrossRef PubMed
41. Howard, J. K. and Flier, J. S. (2006) Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol. Metab. 17, 365-371 CrossRef PubMed (Pubitemid 44596259)
42. Emanuelli, B., Peraldi, P., Filloux, C., Sawka-Verhelle, D., Hilton, D. and Van Obberghen, E. (2000) SOCS-3 is an insulin-induced negative regulator of insulin signaling. J. Biol. Chem. 275, 15985-15991 CrossRef PubMed (Pubitemid 30366903)
43. Bjorbaek, C., Lavery, H. J., Bates, S. H., Olson, R. K., Davis, S. M., Flier, J. S. and Myers, Jr, M. G. (2000) SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J. Biol. Chem. 275, 40649-40657 CrossRef PubMed (Pubitemid 32064706)
44. Steppan, C. M., Wang, J., Whiteman, E. L., Birnbaum, M. J. and Lazar, M. A. (2005) Activation of SOCS-3 by resistin. Mol. Cell Biol. 25, 1569-1575 CrossRef PubMed (Pubitemid 40204931)
45. Bjorbaek, C., Elmquist, J. K., El-Haschimi, K., Kelly, J., Ahima, R. S., Hileman, S. and Flier, J. S. (1999) Activation of SOCS-3 messenger ribonucleic acid in the hypothalamus by ciliary neurotrophic factor. Endocrinology 140, 2035-2043 CrossRef PubMed (Pubitemid 30636440)
46. Pezet, A., Favre, H., Kelly, P. A. and Edery, M. (1999) Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling. J. Biol. Chem. 274, 24497-24502 CrossRef PubMed
47. Rieusset, J., Bouzakri, K., Chevillotte, E., Ricard, N., Jacquet, D., Bastard, J. P., Laville, M. and Vidal, H. (2004) Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients. Diabetes 53, 2232-2241 CrossRef PubMed (Pubitemid 39145576)
48. Steinberg, G. R., McAinch, A. J., Chen, M. B., O'Brien, P. E., Dixon, J. B., Cameron-Smith, D. and Kemp, B. E. (2006) The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. J. Clin. Endocrinol. Metab. 91, 3592-3597 CrossRef PubMed (Pubitemid 44402142)
49. Gylvin, T., Nolsoe, R., Hansen, T., Nielsen, E. M., Bergholdt, R., Karlsen, A. E., Billestrup, N., Borch-Johnsen, K., Pedersen, O., Mandrup-Poulsen, T., Nerup, J. and Pociot, F. (2004) Mutation analysis of suppressor of cytokine signalling 3, a candidate gene in Type 1 diabetes and insulin sensitivity. Diabetologia 47, 1273-1277 CrossRef PubMed (Pubitemid 39093323)
50. Talbert, M. E., Langefeld, C. D., Ziegler, J., Mychaleckyj, J. C., Haffner, S. M., Norris, J. M. and Bowden, D. W. (2009) Polymorphisms near SOCS3 are associated with obesity and glucose homeostasis traits in Hispanic Americans from the Insulin Resistance Atherosclerosis Family Study. Hum. Genet. 125, 153-162 CrossRef PubMed
51. Jamshidi, Y., Snieder, H., Wang, X., Spector, T. D., Carter, N. D. and O'Dell, S. D. (2006) Common polymorphisms in SOCS3 are not associated with body weight, insulin sensitivity or lipid profile in normal female twins. Diabetologia 49, 306-310 CrossRef PubMed (Pubitemid 43185399)
52. Zhang, Y., Zhou, B., Zhang, F., Wu, J., Hu, Y., Liu, Y. and Zhai, Q. (2012) Amyloid-β induces hepatic insulin resistance by activating JAK2/STAT3/SOCS-1 signaling pathway. Diabetes 61, 1434-1443 CrossRef PubMed
53. Cancello, R., Henegar, C., Viguerie, N., Taleb, S., Poitou, C., Rouault, C., Coupaye, M., Pelloux, V., Hugol, D., Bouillot, J. L. et al. (2005) Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54, 2277-2286 CrossRef PubMed (Pubitemid 41134253)
54. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L. and Ferrante, Jr, A. W. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808 CrossRef PubMed (Pubitemid 38063703)
55. Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A. and Chen, H. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821-1830 CrossRef PubMed (Pubitemid 38063705)
56. Hosogai, N., Fukuhara, A., Oshima, K., Miyata, Y., Tanaka, S., Segawa, K., Furukawa, S., Tochino, Y., Komuro, R., Matsuda, M. and Shimomura, I. (2007) Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56, 901-911 CrossRef PubMed (Pubitemid 46525054)
57. Wang, B., Wood, I. S. and Trayhurn, P. (2007) Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflügers Arch. 455, 479-492 CrossRef (Pubitemid 47624196)
58. Ye, J., Gao, Z., Yin, J. and He, Q. (2007) Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob /ob and dietary obese mice. Am. J. Physiol. Endocrinol. Metab. 293, E1118-E1128 CrossRef PubMed (Pubitemid 47535846)
59. Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A. S. and Obin, M. S. (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 46, 2347-2355 CrossRef PubMed (Pubitemid 41532523)
60. Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H. and Flier, J. S. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015-3025 CrossRef PubMed (Pubitemid 44684486)
61. Tsukumo, D. M., Carvalho-Filho, M. A., Carvalheira, J. B., Prada, P. O., Hirabara, S. M., Schenka, A. A., Araujo, J., Vassallo, E. P., Curi, R., Velloso, L. A. and Saad, M. J. (2007) Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56, 1986-1998 CrossRef PubMed (Pubitemid 47195825)
62. Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J., Goldfine, A. B., Benoist, C., Shoelson, S. and Mathis, D. (2009) Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15, 930-939 CrossRef PubMed
63. Nishimura, S. (2012) In vivo imaging reveals adipose tissue inflammation in obesity and multi-cellular processes of developing thrombus. Yakugaku. Zasshi. 132, 425-431 CrossRef PubMed
64. Winer, S., Chan, Y., Paltser, G., Truong, D., Tsui, H., Bahrami, J., Dorfman, R., Wang, Y., Zielenski, J., Mastronardi, F. et al. (2009) Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 15, 921-929 CrossRef PubMed
65. Ferrante, Jr, A. W. (2013) The immune cells in adipose tissue. Diabetes Obes. Metab. 15, 34-38 CrossRef PubMed
66. Chong, M. M., Metcalf, D., Jamieson, E., Alexander, W. S. and Kay, T. W. (2005) Suppressor of cytokine signaling-1 in T cells and macrophages is critical for preventing lethal inflammation. Blood 106, 1668-1675 CrossRef PubMed (Pubitemid 41208580)
67. Starr, R., Metcalf, D., Elefanty, A. G., Brysha, M., Willson, T. A., Nicola, N. A., Hilton, D. J. and Alexander, W. S. (1998) Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. U.S.A. 95, 14395-14399 CrossRef PubMed (Pubitemid 28549378)
68. Alexander, W. S., Starr, R., Fenner, J. E., Scott, C. L., Handman, E., Sprigg, N. S., Corbin, J. E., Cornish, A. L., Darwiche, R., Owczarek, C. M. et al. (1999) SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98, 597-608 CrossRef PubMed (Pubitemid 29418951)
69. Tanaka, K., Ichiyama, K., Hashimoto, M., Yoshida, H., Takimoto, T., Takaesu, G., Torisu, T., Hanada, T., Yasukawa, H., Fukuyama, S., Inoue, H. et al. (2008) Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-γ on STAT3 and Smads. J. Immunol. 180, 3746-3756 CrossRef PubMed
70. Horino, J., Fujimoto, M., Terabe, F., Serada, S., Takahashi, T., Soma, Y., Tanaka, K., Chinen, T., Yoshimura, A., Nomura, S., Kawase, I. et al. (2011) SOCS1 regulates type I/type II NKT cell balance by regulating IFNγ signaling. Int. Immunol. 23, 165-176 CrossRef PubMed
71. Hashimoto, M., Hiwatashi, K., Ichiyama, K., Morita, R., Sekiya, T., Kimura, A., Sugiyama, Y., Sibata, T., Kuroda, K., Takahashi, R. and Yoshimura, A. (2011) SOCS1 regulates type I/type II NKT cell balance by regulating IFNγ signaling. Int. Immunol. 23, 165-176 CrossRef PubMed
72. Takahashi, R., Nishimoto, S., Muto, G., Sekiya, T., Tamiya, T., Kimura, A., Morita, R., Asakawa, M., Chinen, T. and Yoshimura, A. (2011) SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-γ and IL-17A production. J. Exp. Med. 208, 2055-2067 CrossRef PubMed
73. McGillicuddy, F. C., Chiquoine, E. H., Hinkle, C. C., Kim, R. J., Shah, R., Roche, H. M., Smyth, E. M. and Reilly, M. P. (2009) Interferon γ attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway. J. Biol. Chem. 284, 31936-31944 CrossRef PubMed
74. Pacifico, L., Di Renzo, L., Anania, C., Osborn, J. F., Ippoliti, F., Schiavo, E. and Chiesa, C. (2006) Increased T-helper interferon-γ- secreting cells in obese children. Eur. J. Endocrinol. 154, 691-697 CrossRef PubMed (Pubitemid 43810855)
75. Rocha, V. Z., Folco, E. J., Sukhova, G., Shimizu, K., Gotsman, I., Vernon, A. H. and Libby, P. (2008) Interferon-γ, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ. Res. 103, 467-476 CrossRef PubMed
76. Strissel, K. J., DeFuria, J., Shaul, M. E., Bennett, G., Greenberg, A. S. and Obin, M. S. (2010) T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity 18, 1918-1925 CrossRef PubMed
77. Wong, N., Fam, B. C., Cempako, G. R., Steinberg, G. R., Walder, K., Kay, T. W., Proietto, J. and Andrikopoulos, S. (2011) Deficiency in interferon-γ results in reduced body weight and better glucose tolerance in mice. Endocrinology 152, 3690-3699 CrossRef PubMed
78. Yu, C. R., Mahdi, R. M., Ebong, S., Vistica, B. P., Gery, I. and Egwuagu, C. E. (2003) Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells. J. Biol. Chem. 278, 29752-29759 CrossRef PubMed (Pubitemid 36962361)
79. + regulatory T cells and SOCS3-mediated suppression of Treg function. Eur. J. Immunol. 37, 2082-2089 CrossRef PubMed
80. Brender, C., Tannahill, G. M., Jenkins, B. J., Fletcher, J., Columbus, R., Saris, C. J., Ernst, M., Nicola, N. A., Hilton, D. J., Alexander, W. S. and Starr, R. (2007) Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27. Blood 110, 2528-2536 CrossRef PubMed (Pubitemid 47523175)
81. Moriwaki, A., Inoue, H., Nakano, T., Matsunaga, Y., Matsuno, Y., Matsumoto, T., Fukuyama, S., Kan, O. K., Matsumoto, K., Tsuda-Eguchi, M. et al. (2011) T cell treatment with small interfering RNA for suppressor of cytokine signaling 3 modulates allergic airway responses in a murine model of asthma. Am. J. Respir. Cell Mol. Biol. 44, 448-455 CrossRef PubMed
82. Kinjyo, I., Inoue, H., Hamano, S., Fukuyama, S., Yoshimura, T., Koga, K., Takaki, H., Himeno, K., Takaesu, G., Kobayashi, T. and Yoshimura, A. (2006) Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-β 1. J. Exp. Med. 203, 1021-1031 CrossRef PubMed
83. Hausman, G. J. and Richardson, R. L. (2004) Adipose tissue angiogenesis. J. Anim. Sci. 82, 925-934 PubMed (Pubitemid 38572359)
84. Ahmad, R., Al-Mass, A., Atizado, V., Al-Hubail, A., Al-Ghimlas, F., Al-Arouj, M., Bennakhi, A., Dermime, S. and Behbehani, K. (2012) Elevated expression of the toll like receptors 2 and 4 in obese individuals: its significance for obesity-induced inflammation. J. Inflamm. 9, 48 CrossRef
85. Hardy, O. T., Kim, A., Ciccarelli, C., Hayman, L. L. and Wiecha, J. (2013) Increased Toll-like receptor (TLR) mRNA expression in monocytes is a feature of metabolic syndrome in adolescents. Pediatr. Obes. 8, e19-23 CrossRef PubMed
86. Reyna, S. M., Ghosh, S., Tantiwong, P., Meka, C. S., Eagan, P., Jenkinson, C. P., Cersosimo, E., Defronzo, R. A., Coletta, D. K., Sriwijitkamol, A. and Musi, N. (2008) Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects. Diabetes 57, 2595-2602 CrossRef PubMed
87. Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C. et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761-1772 CrossRef PubMed (Pubitemid 47025442)
88. Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R. and Gordon, J. I. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031 CrossRef PubMed (Pubitemid 46018515)
89. Hwang, D. (2001) Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through toll-like receptor 4-derived signaling pathways. FASEB J. 15, 2556-2564 CrossRef PubMed
90. Erridge, C. and Samani, N. J. (2009) Saturated fatty acids do not directly stimulate Toll-like receptor signaling. Arterioscler. Thromb. Vasc. Biol. 29, 1944-1949 CrossRef PubMed
91. Kimura, A., Naka, T., Muta, T., Takeuchi, O., Akira, S., Kawase, I. and Kishimoto, T. (2005) Suppressor of cytokine signaling-1 selectively inhibits LPS-induced IL-6 production by regulating JAK-STAT. Proc. Natl. Acad. Sci. U.S.A. 102, 17089-17094 CrossRef PubMed (Pubitemid 41692688)
92. Mansell, A., Smith, R., Doyle, S. L., Gray, P., Fenner, J. E., Crack, P. J., Nicholson, S. E., Hilton, D. J., O'Neill, L. A. and Hertzog, P. J. (2006) Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat. Immunol. 7, 148-155 CrossRef PubMed (Pubitemid 43135880)
93. Nakagawa, R., Naka, T., Tsutsui, H., Fujimoto, M., Kimura, A., Abe, T., Seki, E., Sato, S., Takeuchi, O., Takeda, K. et al. (2002) SOCS-1 participates in negative regulation of LPS responses. Immunity 17, 677-687 CrossRef PubMed (Pubitemid 35351512)
94. Ryo, A., Suizu, F., Yoshida, Y., Perrem, K., Liou, Y. C., Wulf, G., Rottapel, R., Yamaoka, S. and Lu, K. P. (2003) Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 12, 1413-1426 CrossRef PubMed (Pubitemid 38037011)
95. Sachithanandan, N., Graham, K. L., Galic, S., Honeyman, J. E., Fynch, S. L., Hewitt, K. A., Steinberg, G. R. and Kay, T. W. (2011) Macrophage deletion of SOCS1 increases sensitivity to LPS and palmitic acid and results in systemic inflammation and hepatic insulin resistance. Diabetes 60, 2023-2031 CrossRef PubMed
96. Huang, W., Metlakunta, A., Dedousis, N., Zhang, P., Sipula, I., Dube, J. J., Scott, D. K. and O'Doherty, R. M. (2010) Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes 59, 347-357 CrossRef PubMed
97. Whyte, C. S., Bishop, E. T., Ruckerl, D., Gaspar-Pereira, S., Barker, R. N., Allen, J. E., Rees, A. J. and Wilson, H. M. (2011) Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function. J. Leukoc. Biol. 90, 845-854 CrossRef PubMed
98. Gylvin, T., Ek, J., Nolsoe, R., Albrechtsen, A., Andersen, G., Bergholdt, R., Brorsson, C., Bang-Berthelsen, C. H., Hansen, T., Karlsen, A. E. et al. (2009) Functional SOCS1 polymorphisms are associated with variation in obesity in whites. Diabetes Obes. Metab. 11, 196-203 CrossRef PubMed
99. Spence, S., Fitzsimons, A., Boyd, C. R., Kessler, J., Fitzgerald, D., Elliott, J., Gabhann, J. N., Smith, S., Sica, A., Hams, E. et al. (2013) Suppressors of cytokine signaling 2 and 3 diametrically control macrophage polarization. Immunity 38, 66-78 CrossRef PubMed
100. Yasukawa, H., Ohishi, M., Mori, H., Murakami, M., Chinen, T., Aki, D., Hanada, T., Takeda, K., Akira, S., Hoshijima, M. et al. (2003) IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat. Immunol. 4, 551-556 CrossRef PubMed (Pubitemid 36701338)
101. Pedersen, B. K. and Febbraio, M. A. (2008) Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol. Rev. 88, 1379-1406 CrossRef PubMed
102. Qin, H., Holdbrooks, A. T., Liu, Y., Reynolds, S. L., Yanagisawa, L. L. and Benveniste, E. N. (2012) SOCS3 deficiency promotes M1 macrophage polarization and inflammation. J. Immunol. 189, 3439-3448 CrossRef PubMed
103. Galic, S., Fullerton, M. D., Schertzer, J. D., Sikkema, S., Marcinko, K., Walkley, C. R., Izon, D., Honeyman, J., Chen, Z. P., van Denderen, B. J. et al. (2011) Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. J. Clin. Invest. 121, 4903-4915 CrossRef PubMed
104. 307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 277, 1531-1537 CrossRef PubMed
105. Mothe, I. and Van Obberghen, E. (1996) Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action. J. Biol. Chem. 271, 11222-11227 CrossRef PubMed (Pubitemid 26155955)
106. Paz, K., Hemi, R., LeRoith, D., Karasik, A., Elhanany, E., Kanety, H. and Zick, Y. (1997) A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J. Biol. Chem. 272, 29911-29918 CrossRef PubMed
107. Gual, P., Le Marchand-Brustel, Y. and Tanti, J. F. (2005) Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87, 99-109 CrossRef PubMed (Pubitemid 40298772)
108. Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, B. A., White, M. F. and Spiegelman, B. M. (1996) IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 271, 665-668 CrossRef PubMed (Pubitemid 26052915)
109. Liu, Y. F., Herschkovitz, A., Boura-Halfon, S., Ronen, D., Paz, K., Leroith, D. and Zick, Y. (2004) Serine phosphorylation proximal to its phosphotyrosine binding domain inhibits insulin receptor substrate 1 function and promotes insulin resistance. Mol. Cell Biol. 24, 9668-9681 CrossRef PubMed (Pubitemid 39391701)
110. Craparo, A., Freund, R. and Gustafson, T. A. (1997) 14-3-3 ε interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner. J. Biol. Chem. 272, 11663-11669 CrossRef PubMed (Pubitemid 27184180)
111. Xiang, X., Yuan, M., Song, Y., Ruderman, N., Wen, R. and Luo, Z. (2002) 14-3-3 facilitates insulin-stimulated intracellular trafficking of insulin receptor substrate 1. Mol. Endocrinol. 16, 552-562 CrossRef PubMed (Pubitemid 34214574)
112. Pederson, T. M., Kramer, D. L. and Rondinone, C. M. (2001) Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation. Diabetes 50, 24-31 CrossRef PubMed (Pubitemid 32047976)
113. Sun, X. J., Goldberg, J. L., Qiao, L. Y. and Mitchell, J. J. (1999) Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes 48, 1359-1364 CrossRef PubMed (Pubitemid 29297296)
114. Copps, K. D., Hancer, N. J., Opare-Ado, L., Qiu, W., Walsh, C. and White, M. F. (2010) Irs1 serine 307 promotes insulin sensitivity in mice. Cell. Metab. 11, 84-92 CrossRef PubMed
115. 307 phosphorylation does not mediate mTORC1-induced insulin resistance. Biochem. Biophys. Res. Commun. 443, 689-693 CrossRef PubMed
116. Dey, B. R., Furlanetto, R. W. and Nissley, P. (2000) Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor. Biochem Biophys Res Commun 278, 38-43 CrossRef PubMed
117. Dey, B. R., Spence, S. L., Nissley, P. and Furlanetto, R. W. (1998) Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor. J. Biol. Chem. 273, 24095-24101 CrossRef PubMed (Pubitemid 28435753)
118. Mooney, R. A., Senn, J., Cameron, S., Inamdar, N., Boivin, L. M., Shang, Y. and Furlanetto, R. W. (2001) Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance. J. Biol. Chem. 276, 25889-25893 CrossRef PubMed
119. Krebs, D. L., Uren, R. T., Metcalf, D., Rakar, S., Zhang, J. G., Starr, R., De Souza, D. P., Hanzinikolas, K., Eyles, J., Connolly, L. M. et al. (2002) SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation. Mol. Cell Biol. 22, 4567-4578 CrossRef PubMed (Pubitemid 34620394)
120. Rui, L., Yuan, M., Frantz, D., Shoelson, S. and White, M. F. (2002) SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277, 42394-42398 CrossRef PubMed (Pubitemid 35257562)
121. Ueki, K., Kadowaki, T. and Kahn, C. R. (2005) Role of suppressors of cytokine signaling SOCS-1 and SOCS-3 in hepatic steatosis and the metabolic syndrome. Hepatol. Res. 33, 185-192 CrossRef PubMed (Pubitemid 41799802)
122. Shi, H., Cave, B., Inouye, K., Bjorbaek, C. and Flier, J. S. (2006) Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance. Diabetes 55, 699-707 CrossRef PubMed (Pubitemid 43343226)
123. Yang, Z., Hulver, M., McMillan, R. P., Cai, L., Kershaw, E. E., Yu, L.,
124. Lebrun, P., Cognard, E., Bellon-Paul, R., Gontard, P., Filloux, C., Jehl-Pietri, C., Grimaldi, P., Samson, M., Penicaud, L., Ruberte, J. et al. (2009) Constitutive expression of suppressor of cytokine signalling-3 in skeletal muscle leads to reduced mobility and overweight in mice. Diabetologia 52, 2201-2212 CrossRef PubMed
125. Gual, P., Baron, V., Lequoy, V. and Van Obberghen, E. (1998) Interaction of Janus kinases JAK-1 and JAK-2 with the insulin receptor and the insulin-like growth factor-1 receptor. Endocrinology 139, 884-893 PubMed (Pubitemid 28510102)
126. Kawazoe, Y., Naka, T., Fujimoto, M., Kohzaki, H., Morita, Y., Narazaki, M., Okumura, K., Saitoh, H., Nakagawa, R., Uchiyama, S. et al. (2001) Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation. J. Exp. Med. 193, 263-269 CrossRef PubMed (Pubitemid 32524458)
127. Carvalheira, J. B., Ribeiro, E. B., Folli, F., Velloso, L. A. and Saad, M. J. (2003) Interaction between leptin and insulin signaling pathways differentially affects JAK-STAT and PI 3-kinase-mediated signaling in rat liver. Biol. Chem. 384, 151-159 CrossRef PubMed (Pubitemid 36322641)
128. Jamieson, E., Chong, M. M., Steinberg, G. R., Jovanovska, V., Fam, B. C., Bullen, D. V., Chen, Y., Kemp, B. E., Proietto, J., Kay, T. W. and Andrikopoulos, S. (2005) Socs1 deficiency enhances hepatic insulin signaling. J. Biol. Chem. 280, 31516-31521 CrossRef PubMed (Pubitemid 41291894)
129. Emanuelli, B., Macotela, Y., Boucher, J. and Ronald Kahn, C. (2008) SOCS-1 deficiency does not prevent diet-induced insulin resistance. Biochem. Biophys. Res. Commun. 377, 447-452 CrossRef PubMed
130. Zadjali, F., Santana-Farre, R., Vesterlund, M., Carow, B., Mirecki-Garrido, M., Hernandez-Hernandez, I., Flodstrom-Tullberg, M., Parini, P., Rottenberg, M., Norstedt, G. et al. (2012) SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice. FASEB J. 26, 3282-3291 CrossRef PubMed
131. Kato, H., Nomura, K., Osabe, D., Shinohara, S., Mizumori, O., Katashima, R., Iwasaki, S., Nishimura, K., Yoshino, M., Kobori, M., Ichiishi, E. et al. (2006) Association of single-nucleotide polymorphisms in the suppressor of cytokine signaling 2 (SOCS2) gene with type 2 diabetes in the Japanese. Genomics 87, 446-458 CrossRef PubMed
132. Palanivel, R., Fullerton, M. D., Galic, S., Honeyman, J., Hewitt, K. A., Jorgensen, S. B. and Steinberg, G. R. (2012) Reduced Socs3 expression in adipose tissue protects female mice against obesity-induced insulin resistance. Diabetologia 55, 3083-3093 CrossRef PubMed
133. Leong, G. M., Moverare, S., Brce, J., Doyle, N., Sjogren, K., Dahlman-Wright, K., Gustafsson, J. A., Ho, K. K., Ohlsson, C. and Leung, K. C. (2004) Estrogen up-regulates hepatic expression of suppressors of cytokine signaling-2 and -3 in vivo and in vitro. Endocrinology 145, 5525-5531 CrossRef PubMed (Pubitemid 39564592)
134. Torisu, T., Sato, N., Yoshiga, D., Kobayashi, T., Yoshioka, T., Mori, H., Iida, M. and Yoshimura, A. (2007) The dual function of hepatic SOCS3 in insulin resistance in vivo. Genes Cells 12, 143-154 CrossRef PubMed (Pubitemid 46152654)
135. Sachithanandan, N., Fam, B. C., Fynch, S., Dzamko, N., Watt, M. J., Wormald, S., Honeyman, J., Galic, S., Proietto, J., Andrikopoulos, S. et al. (2010) Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity. Hepatology 52, 1632-1642 CrossRef PubMed
136. Munzberg, H., Flier, J. S. and Bjorbaek, C. (2004) Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 145, 4880-4889 CrossRef PubMed (Pubitemid 39551104)
137. Yaspelkis, III, B. B., Kvasha, I. A. and Figueroa, T. Y. (2009) High-fat feeding increases insulin receptor and IRS-1 coimmunoprecipitation with SOCS-3, IKKα/β phosphorylation and decreases PI-3 kinase activity in muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296, R1709-R1715 CrossRef
138. Jorgensen, S. B., O'Neill, H. M., Sylow, L., Honeyman, J., Hewitt, K. A., Palanivel, R., Fullerton, M. D., Oberg, L., Balendran, A., Galic, S. et al. (2013) Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesity. Diabetes 62, 56-64 CrossRef PubMed
139. Tellechea, M. L., Steinhardt, A. P., Rodriguez, G., Taverna, M. J., Poskus, E. and Frechtel, G. (2013) Common variants in SOCS7 gene predict obesity, disturbances in lipid metabolism and insulin resistance. Nutr. Metab. Cardiovasc. Dis. 23, 424-431 CrossRef PubMed
140. Nakashima, T., Yokoyama, A., Onari, Y., Shoda, H., Haruta, Y., Hattori, N., Naka, T. and Kohno, N. (2008) Suppressor of cytokine signaling 1 inhibits pulmonary inflammation and fibrosis. J. Allergy Clin. Immunol. 121, 1269-1276 CrossRef PubMed
141. Egan, P. J., Lawlor, K. E., Alexander, W. S. and Wicks, I. P. (2003) Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation. J. Clin. Invest. 111, 915-924 CrossRef PubMed (Pubitemid 37074967)
142. He, B., You, L., Uematsu, K., Zang, K., Xu, Z., Lee, A. Y., Costello, J. F., McCormick, F. and Jablons, D. M. (2003) SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc. Natl. Acad. Sci. U.S.A. 100, 14133-14138 CrossRef PubMed (Pubitemid 37499203)
143. Niwa, Y., Kanda, H., Shikauchi, Y., Saiura, A., Matsubara, K., Kitagawa, T., Yamamoto, J., Kubo, T. and Yoshikawa, H. (2005) Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma. Oncogene 24, 6406-6417 PubMed (Pubitemid 41486474)
144. Weniger, M. A., Melzner, I., Menz, C. K., Wegener, S., Bucur, A. J., Dorsch, K., Mattfeldt, T., Barth, T. F. and Moller, P. (2006) Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation. Oncogene 25, 2679-2684 CrossRef PubMed
145. Yoshida, T., Ogata, H., Kamio, M., Joo, A., Shiraishi, H., Tokunaga, Y., Sata, M., Nagai, H. and Yoshimura, A. (2004) SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis. J. Exp. Med. 199, 1701-1707 CrossRef PubMed (Pubitemid 38822003)